Marinomed Biotech AG is an Austrian, science-driven biotech company with a growing development pipeline and globally marketed therapeutics. The Company focuses on the development of innovative, patent-protected products in the therapeutic areas of respiratory and ophthalmic diseases, based on the proprietary Marinosolv® platform. The Marinosolv® technology significantly improves the solubility and bioavailability of hardly soluble compounds, enabling the development of novel therapies for immune-related and inflammatory disorders. Under the brand Solv4U Marinomed offers drug development in all stages, based on its patent protected Marinosolv® technology platform. The Company’s Carragelose®-based OTC business was successfully sold to Unither Pharmaceuticals in 2025 Headquartered in Korneuburg, Austria, Marinomed is listed on the standard market of the Vienna Stock Exchange (VSE:MARI). https://www.marinomed.com/en/data-protection-declaration https://www.marinomed.com/en/legal-notice
| Website | https://www.marinomed.com/en |
| Revenue | $3 million |
| Employees | 41 (35 on RocketReach) |
| Founded | 2006 |
| Phone | +43 2262 90300 |
| Fax | +43 1 250774493 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology, Drug Stores & Pharmacies, Biopharma, Retail, Drug Discovery, Health Care, Science and Engineering, Medical, Product Design, Design, Therapeutics |
| Keywords | Biotechnology, Immunology, Virology, Therapeutics, Pharmaceutical, Drug Development, Patent Protection, Biopharma, Clinical Development, Antiviral, Pharmaceutical Research, Scientific Research, Medical Technology |
| Competitors | Emergent BioSolutions, Sanofi Pasteur, CureVac, Novavax, Moderna Therapeutics, Valneva, INOVIO Pharmaceuticals, Inc., SEPPIC, Vaxart, Inc., Rallybio +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Marinomed Biotech AG employee's phone or email?
Marinomed Biotech AG Questions
The Marinomed Biotech AG annual revenue was $3 million in 2026.
Andreas Grassauer is the CEO of Marinomed Biotech AG.
35 people are employed at Marinomed Biotech AG.
The NAICS codes for Marinomed Biotech AG are [3254, 325, 32541, 32].
The SIC codes for Marinomed Biotech AG are [28, 283].
Top Marinomed Biotech AG Employees
-
22
-
Gabriele Ram
CFO at Marinomed Biotech AG
Vienna, Austria22 -
13
-
22
Related Companies
